Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can Dobutamine and Goal-Directed Fluid Therapy Improve Tissue Oxygenation in Deep Inferior Epigastric Perforator (DIEP) Flap Breast Reconstruction Surgery? Randomized Controlled Trial

NCT04020172 is registered in ClinicalTrials.gov with Dr. Glenio Mizubuti (MD, PhD) as lead sponsor.

NCT NCT04020172
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04020172 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can Dobutamine and Goal-Directed Fluid Therapy Improve Tissue Oxygenation in Deep Inferior Epigastric Perforator (DIEP) Flap Breast Reconstruction Surgery? Randomized Controlled Trial
Lead sponsor
Dr. Glenio Mizubuti (MD, PhD)
Phase
Phase 1/2
Overall status
Completed
Start date
July 12, 2019
Completion date
May 1, 2024
Enrollment
40 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

perioperative tissue oxygenation